Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among other issues: Out-of-pocket costs are increasingly passed on to consumers.
The FDA commissioner wants drugmakers to “end the shenanigans.”
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”
Amid the protests, funerals and endless meetings, these activists fight, love and dance.
Puerto Rico’s main exports are medical devices and pharmaceuticals, including HIV and cancer drugs.
Scott Gottlieb has said he wants lower costs and faster drug approvals.
But do Scott Gottlieb’s interests lie with drugmakers or patients?
He also told pharma leaders: “We have to get prices down. We have no choice.”
Deborah Waterhouse will lead the global HIV pharma company.
Report by HIV and hepatitis C advocates gives lawmakers and the White House a 100-day road map to tackling drug costs.
Evaluate HIV-related issues in the 2016 election.
Then consider this updated application form that’s good for common HIV patient assistant programs (PAPs).
A look at Proposition 61—the Drug Price Relief Act—before it goes to California voters in November.
ACT UP protest asks: Who gets to influence Hillary Clinton on drug pricing?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.